This title appears in the Scientific Report :
2021
Please use the identifier:
http://dx.doi.org/10.1111/irv.12827 in citations.
Please use the identifier: http://hdl.handle.net/2128/27656 in citations.
Germany’s next shutdown—Possible scenarios and outcomes
Germany’s next shutdown—Possible scenarios and outcomes
In attempting to predict the further course of the novel coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2, mathematical models of different types are frequently employed and calibrated to reported case numbers. Among the major challenges in interpreting these data is the uncertainty abou...
Saved in:
Personal Name(s): | Barbarossa, Maria Vittoria (Corresponding author) |
---|---|
Fuhrmann, Jan | |
Contributing Institute: |
Jülich Supercomputing Center; JSC |
Published in: | Influenza and other respiratory viruses, 15 (2021) 3, S. 326-330 |
Imprint: |
Oxford [u.a.]
Wiley-Blackwell
2021
|
DOI: |
10.1111/irv.12827 |
Document Type: |
Journal Article |
Research Program: |
Domain-Specific Simulation & Data Life Cycle Labs (SDLs) and Research Groups Enabling Computational- & Data-Intensive Science and Engineering |
Link: |
OpenAccess |
Publikationsportal JuSER |
Please use the identifier: http://hdl.handle.net/2128/27656 in citations.
In attempting to predict the further course of the novel coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2, mathematical models of different types are frequently employed and calibrated to reported case numbers. Among the major challenges in interpreting these data is the uncertainty about the amount of undetected infections, or conversely: the detection ratio. As a result, some models make assumptions about the percentage of detected cases among total infections while others completely neglect undetected cases. Here, we illustrate how model projections about case and fatality numbers vary significantly under varying assumptions on the detection ratio. Uncertainties in model predictions can be significantly reduced by representative testing, both for antibodies and active virus RNA, to uncover past and current infections that have gone undetected thus far. |